Hemostasis Today
NewsFeed
Headlines Hematology Health Medicine VTE ASH Plasma Donation
June, 2026
June 2026
M T W T F S S
1234567
891011121314
15161718192021
22232425262728
2930  
Manuel Carbonell: Modern Phlebology Should Not Be a Competition of Devices and Technology
Manuel Carbonell /topdoctors.com.ar
May 9, 2026, 23:50

Manuel Carbonell: Modern Phlebology Should Not Be a Competition of Devices and Technology

Manuel Carbonell, Director at the Center of Phlebology, shared a post on LinkedIn:

” ‘Sclerotherapy begins and ends phlebology.’
– John Bergan

Today I would like to share a clinical case that reflects something that is still often underestimated within our specialty:

Ultrasound-guided foam sclerotherapy: the ‘Cinderella’ of phlebology

Patient with chronic venous insufficiency treated with ultrasound-guided foam sclerotherapy using 5% polidocanol.

Technique:

  • 5% polidocanol
  • Total of 12cc of foam
  • 6cc injected at 10 cm of the saphenofemoral junction
  • 6cc injected at the distal third of the thigh

The post-treatment image corresponds to the first week follow-up.

Clinical evolution:

  • No significant pain
  • No need for anti-inflammatory medication
  • Excellent tolerance
  • Marked symptom reduction
  • Very satisfied patient

At a time when so much attention is focused exclusively on thermal technologies and increasingly sophisticated devices, it is worth remembering that ultrasound-guided foam sclerotherapy remains, in experienced hands and with proper patient selection, an extraordinarily valuable tool.

Modern phlebology should not become a competition of devices and technology, but rather the art of choosing the right treatment for the right anatomy and the right patient.

Ultrasound-guided foam still offers important advantages:

  • Minimally invasive
  • Rapid recovery
  • Very low post-procedural pain
  • Repeatable when necessary
  • Significantly lower costs
  • Excellent tolerance in selected patients

Probably the ‘Cinderella’ of phlebology… yet often one of the most elegant and efficient tools we have.”

Manuel Carbonell: Modern Phlebology Should Not Be a Competition of Devices and Technology

Stay updated with Hemostasis Today.

Health Hematology Hemostasis Hemostasis News Hemostasis Today John Bergan Manuel Carbonell Medicine Phlebology polidocanol sclerotherapy
NewsFeed